← FDA Drug Approvals (Drugs@FDA)
CYCLOPHOSPHAMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EIRGEN · Approved 2024-12-03
Drug application
- FDA Application #
ANDA218282- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CYCLOPHOSPHAMIDE
- Generic name
- CYCLOPHOSPHAMIDE
- Active ingredients
- CYCLOPHOSPHAMIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- EIRGEN
- Manufacturer
- OPKO Pharmaceuticals, LLC
- First approval
- 2024-12-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown